Bi-partisan lawmakers push to include funding for psychedelic research and treatment in sweeping defense bill; AMA reveals full CPT code.
After approving a Current Procedural Terminology (CPT) code for psychedelics, the American Medical Association has released the full language of the new CPT code for continuous in-person monitoring and intervention during psychedelic medication therapy. The code is slated to go into effect and be published in the CPT manual on January 1, 2024. Here’s more: https://www.hmpgloballearningnetwork.com/site/bhe/news/ama-releases-full-language-new-cpt-code-psychedelic-therapies
A bipartisan group of U.S. lawmakers pushed to include a provision allowing medical research of psychedelic drugs as part of a sweeping annual defense policy bill, saying it could help treat post-traumatic stress disorder and other ailments despite possible concerns. Check it out: https://www.reuters.com/world/us/us-lawmakers-make-bipartisan-push-psychedelics-research-defense-bill-2023-07-13/
Political strategists in Massachusetts filed paperwork to put a therapeutic psychedelics legalization initiative on the state’s 2024 ballot.
The newly formed Massachusetts for Mental Health Options (MMHO) committee submitted initial documents to the state Office of Campaign and Political Finance (OCPF), signaling their intent to secure ballot placement for the measure.
A statement filed last week says the group's purpose will be to “expand mental health treatment options in Massachusetts by providing new pathways to access natural psychedelic medicine therapy.”
The filing also says that the forthcoming ballot question will be focused on “creating access to natural psychedelic medicine therapy and removing criminal penalties for personal possession of these medicines.” Here’s more: https://www.marijuanamoment.net/massachusetts-campaign-quietly-takes-first-step-to-put-psychedelics-reform-on-the-2024-ballot/
Did you know that psychedelics could potentially treat women with postpartum depression (PPD)?
In a study published in the Journal of Psychopharmacology, researchers reported that psilocybin could foster a sense of reconnection for mothers suffering from PPD, allowing for improved mood and maternal sensitivity towards their infants, which can positively impact maternal role gratification and the mother-infant relationships. Check it out: https://pubmed.ncbi.nlm.nih.gov/35638179/